Hourly refreshMon, Jul 27, 2026

Press Release Database

Recent press releases, indexed by topic.
AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
Results
Showing all · 44006 itemsDownloadExcelTXT
In the wire

Copper Intelligence Highlights Strategic Positioning Following Executive Order Strengthening Defense Supply Chains and Critical Materials Supply

WASHINGTON, July 27, 2026 /PRNewswire/ -- Copper Intelligence (OTCID: CUAI) highlighted the strategic alignment of its copper exploration and development initiatives following the President of the United States Executive Order, "Securing America's Defense Supply Chains and Ensuring...

Jul 27 · 11:30PR Newswire
Finance · Crypto

DeFi Technologies Issues CEO Letter to Shareholders

TORONTO, July 27, 2026 /PRNewswire/ -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), today issued a Letter to...

Jul 27 · 11:30PR Newswire
In the wire

Edison Lithium Appoints Andrew Gainsbury as CFO and Director, Announces Passing of Director Jay Richardson, and Provides Update on Joutel and Gagne Gold Project Transaction

Vancouver, British Columbia--(Newsfile Corp. - July 27, 2026) - Edison Lithium Corp. (TSXV: EDDY) (OTC Pink: EDDYF) (FSE: VV0) ("Edison" or the "Company") is pleased to announce, subject to the approval of the TSX Venture Exchange, the appointment of Andrew Gainsbury as Chief Financial Officer and Director of the Company effective July 23, 2026.Mr. Gainsbury has served as the Company's acting Chief Financial Officer on an interim basis since March 1, 2026. Prior to assuming that role, Mr....

Jul 27 · 11:30mlpr-newsfile
Finance · Healthcare

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

MILLBRAE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced that the first patient has been dosed in TeLuRide-008, a Phase 2/3 registrational study evaluating EIK1001 in combination with pembrolizumab and histology-appropriate chemotherapy as first-line therapy for treatment-naïve patients with stage 4 Non-Small Cell Lung Cancer (NSCLC).

Jul 27 · 11:30GlobeNewswire
In the wire

Electric Metals Launches Coordinated Investor Relations Program to Expand Investor Awareness Across North America

Jul 27 · 11:30Newswire.com
Finance · Healthcare

Enhanced Applauds FDA Advisory Committee's Landmark Vote to Expand Legal Compounding Pathway for Peptides

NEW YORK, July 27, 2026--Enhanced Group Inc. (NYSE: ENHA) the elite sports competition and personalized performance products company commended the United States Food & Drug Administration’s (FDA) Pharmacy Compounding Advisory Committee (PCAC) for its vote last week recommending that BPC-157, KPV, TB-500, MOTS-c, Epitalon and Semax be added to the FDA's Section 503A Bulk Drug Substances List. This recommendation is a critical step toward providing licensed U.S.

Jul 27 · 11:30mlpr-businesswire
Energy

EVelution Energy Confirms Substantial Groundwater Resources for First Commercial-scale Cobalt Processing Facility in the U.S.

YUMA, Ariz., July 27, 2026--EVelution Energy confirms substantial groundwater resources, further de-risking its planned solar-powered cobalt processing facility in Arizona.

Jul 27 · 11:30mlpr-businesswire
Finance

Frequency Electronics Inc. Announces Space Mission Contract Award Valued at Approximately $8 million

MITCHEL FIELD, N.Y., July 27, 2026 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce the award of a follow-on production contract for approximately $8 million, for compact, highly precise atomic clocks to support position, navigation, and timing (PNT) for lunar space missions.

Jul 27 · 11:30GlobeNewswire
Finance · Healthcare

Glass House Brands Retains Former DEA Compliance Executive to Advise on Interstate Commerce and Export Opportunities

LONG BEACH, Calif. and TORONTO, July 27, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that the Company has retained Matt Murphy, as an advisor on DEA compliance as it relates to instituting regulations related to interstate commerce and the export of medical cannabis compliant with Schedule III regulatory requirements contained in the Controlled Substances Act (CSA).

Jul 27 · 11:30GlobeNewswire
Finance · Energy

Indonesia Energy Corporation Commences Drilling of K-29 Well

The First of Two New Planned Wells at Kruh Block in 2026

Jul 27 · 11:30GlobeNewswire
Healthcare

Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products...

Jul 27 · 11:30PR Newswire
Finance

NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License

NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to L

Jul 27 · 11:30GlobeNewswire
← Prev1233668Next →